Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

ATXI Avenue Therapeutics, Inc. Common Stock
$0.38 -4.75% -0.02
Notify me if price changes either direction
Interactive Brokers Logotype

Buy ATXI stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Avenue Therapeutics, Inc. Common Stock (ATXI)

Loading

Key Stats

Market cap. 1.3M
Enterprise value -673437
Trailing PE 0.37662336
Forward PE -0.122611456
PEG Ratio -0.0012946428
Enterprise to EBITDA 0.19219092465753
Enterprise to revenue -0.47965598290598
Price to book MRQ 2.2254336
Price to sales TTM 0.9485933048433

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 1.4M
Diluted EPS TTM -0.85
Total Cash (MRQ) 1.9M
Current ratio (MRQ) 1.404
Operating Cash Flow (TTM) -1384000

ATXI trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent ATXI News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.